What Is TB-500 Used For, and What Evidence Supports It?

TB-500 is sold for tissue repair and faster recovery, but controlled human research has tested its parent peptide thymosin beta-4, not TB-500 itself. The parent peptide helped wounds close faster in animals and showed early eye and heart signals in small human trials, while tendon, muscle, and workout recovery claims remain unproven.

What is TB-500 and how is it different from thymosin beta-4?

TB-500 is a short lab-made piece that copies a small section of thymosin beta-4. Thymosin beta-4 is a 43-amino-acid peptide, a short chain of protein building blocks found in many tissues, where it helps cells move and supports formation of new blood vessels during repair (BSCG review).

Sellers market TB-500 for tendon and muscle strains, ligament irritation, skin wounds, and faster bounce-back from training. No controlled human trial has tested TB-500 itself (BSCG review). Sport authorities prohibit thymosin beta-4 and its derivatives including TB-500 at all times.

What have human and animal studies actually found?

A 2026 evidence map screened 1,772 records and kept 80 studies. Human research clustered in eye and skin wound care, while tendon, ligament, muscle, and cartilage research was sparse and direct TB-500 evidence was limited to a single study (evidence map).

In rats with full-thickness skin wounds, parent-peptide treatment closed the surface faster than saline, and treated wounds showed more collagen and new vessel growth (rat wound study).

In people with moderate to severe dry eye, 0.1% parent-peptide eye drops for 28 days missed the two main measures, but comfort during a dry-eye challenge improved and two measures of corneal surface staining improved. No adverse events were reported in that trial (dry-eye trial).

In people treated after a major heart attack and stent procedure, those who received parent peptide within hours had less scarred area at 90 days, while the full trial group showed no clear difference. Mouse experiments linked the effect to a cell-survival pathway (heart trial). In healthy volunteers given intravenous parent peptide once and then daily for two weeks, side effects were infrequent and mild to moderate, with no dose-limiting toxicity or serious events (safety study).

Does it make sense for injury or workout recovery?

Training recovery is where the gap is widest. Tendon and muscle claims rest on animal biology and mechanism. Human recovery trials are missing, and eye-drop or heart-infusion results do not tell you how a strained hamstring or sore Achilles will respond.

TB-500 has no FDA approval for any use, and FDA lists this fragment among bulk substances that may present significant safety risks in compounding because human exposure and safety data are limited (evidence map).

If slow recovery keeps cutting into your training, take the HOD quiz for a clinician-reviewed recovery plan built around options with human data and verified pharmacy sourcing.